title: [Treatment of chronic hepatitis C with peginterferon alpha-2a and the factors influencing the effect of this treatment].
authors.affiliation: Clinical Virology Research Unit, Ruijin Hospital, Shanghai Second Medical University, Shanghai 200025, China.
authors.forename: Gen-Di
authors.initials: GD
authors.lastname: Jin
authors.forename: Qi-Ming
authors.initials: QM
authors.lastname: Gong
authors.forename: Hong-Ju
authors.initials: HJ
authors.lastname: Mao
authors.forename: Dao-Zhen
authors.initials: DZ
authors.lastname: Xu
authors.forename: Zhi-Meng
authors.initials: ZM
authors.lastname: Lu
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D011994:Recombinant Proteins
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C100416:peginterferon alfa-2a